Development of an immunocytochemical assay to detect human CFTR expression following gene therapy

Ian A Pringle, LA Davies, AE Lawton, H Painter, N Evans, A-M Green, D McCormick, C Stoneham, RL Coles, S Sumner-Jones, G Nunez-Alonso, R Scheule, SH Cheng, DR Gill & SC Hyde 1. GeneMedicine Group, NDCLS, John Radcliffe Hospital, University of Oxford, Oxford, UK. 2. Genzyme Corporation, Framingham, MA, USA. 3. The United Kingdom Cystic Fibrosis Gene Therapy Consortium, www.cfgenetherapy.org.uk All GeneMedicine Group posters are available at:http://users.ox.ac.uk/~genemed ian.pringle@trinity.ox.ac.uk